Nutriband Inc. (NASDAQ:NTRBW – Get Free Report)’s stock price dropped 8.9% during mid-day trading on Tuesday . The company traded as low as $0.35 and last traded at $0.41. 5,500 shares traded hands during trading, an increase of 49% from the average session volume of 3,689 shares. The stock had previously closed at $0.45.
Nutriband Trading Down 8.9%
The company’s fifty day moving average price is $0.60 and its 200 day moving average price is $1.02.
Hedge Funds Weigh In On Nutriband
An institutional investor recently bought a new position in Nutriband stock. Empery Asset Management LP acquired a new stake in Nutriband Inc. (NASDAQ:NTRBW – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 40,218 shares of the company’s stock, valued at approximately $65,000. Nutriband makes up about 0.1% of Empery Asset Management LP’s portfolio, making the stock its 20th largest holding.
Nutriband Company Profile
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.
Further Reading
- Five stocks we like better than Nutriband
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
